Technical Analysis for HYPR - Hyperfine, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.81 | 0.63% | 0.01 |
HYPR closed down 3.28 percent on Tuesday, May 7, 2024, on 56 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.61% | |
Outside Day | Range Expansion | 0.61% | |
Wide Bands | Range Expansion | 0.61% | |
Gapped Up | Strength | 0.61% | |
Oversold Stochastic | Weakness | 0.61% | |
MACD Bullish Signal Line Cross | Bullish | -2.68% | |
Narrow Range Bar | Range Contraction | -2.68% | |
Wide Bands | Range Expansion | -2.68% | |
Gapped Up | Strength | -2.68% | |
Oversold Stochastic | Weakness | -2.68% |
Alert | Time |
---|---|
Down 1% | 2 minutes ago |
60 Minute Opening Range Breakdown | about 1 hour ago |
10 DMA Resistance | about 1 hour ago |
20 DMA Resistance | about 2 hours ago |
Rose Above 20 DMA | about 2 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Hyperfine was founded with a vision to save lives by making Magnetic Resonance Imaging (MRI) more accessible and affordable. Hyperfine's portable Swoop™ system is the world's first FDA-cleared bedside MRI system. Hyperfine was founded in 2014 by Jonathan Rothberg, Ph.D., a serial entrepreneur and the founder or co-founder of numerous other innovative companies, including CuraGen, 454 Life Sciences, Ion Torrent, RainDance Technologies, ClariFI, Quantum-Si, AI Therapeutics, Butterfly Network, 4Catalyzer, and 4Bionics. In 2015, Rothberg was awarded the National Medal of Technology and Innovation by President Obama for inventing and commercializing DNA sequencing.
Sector: Healthcare
Industry: Medical Devices
Keywords: Life Sciences Biology Natural Sciences FDA MRI Magnetic Resonance Magnetic Resonance Imaging DNA Sequencing Jonathan Rothberg
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Life Sciences Biology Natural Sciences FDA MRI Magnetic Resonance Magnetic Resonance Imaging DNA Sequencing Jonathan Rothberg
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.28 |
52 Week Low | 0.77 |
Average Volume | 90,871 |
200-Day Moving Average | 1.44 |
50-Day Moving Average | 1.00 |
20-Day Moving Average | 0.87 |
10-Day Moving Average | 0.81 |
Average True Range | 0.07 |
RSI (14) | 35.90 |
ADX | 19.69 |
+DI | 12.37 |
-DI | 17.69 |
Chandelier Exit (Long, 3 ATRs) | 0.87 |
Chandelier Exit (Short, 3 ATRs) | 0.98 |
Upper Bollinger Bands | 1.03 |
Lower Bollinger Band | 0.71 |
Percent B (%b) | 0.29 |
BandWidth | 37.58 |
MACD Line | -0.06 |
MACD Signal Line | -0.06 |
MACD Histogram | 0.0024 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.87 | ||||
Resistance 3 (R3) | 0.88 | 0.87 | 0.86 | ||
Resistance 2 (R2) | 0.87 | 0.85 | 0.86 | 0.86 | |
Resistance 1 (R1) | 0.83 | 0.84 | 0.83 | 0.83 | 0.85 |
Pivot Point | 0.82 | 0.82 | 0.81 | 0.81 | 0.82 |
Support 1 (S1) | 0.78 | 0.80 | 0.78 | 0.78 | 0.75 |
Support 2 (S2) | 0.77 | 0.79 | 0.76 | 0.74 | |
Support 3 (S3) | 0.73 | 0.77 | 0.74 | ||
Support 4 (S4) | 0.73 |